Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer

E-ISSN： 1873-5576|15|1|71-86

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.1, 2015-01, pp. : 71-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Multimodal Liposomes for Nano-delivery and Imaging: An Avenger for Drug Resistance and Cancer

Current Gene Therapy, Vol. 13, Iss. 5, 2013-10 ,pp. : 322-334

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer

Current Cancer Drug Targets, Vol. 9, Iss. 2, 2009-03 ,pp. : 148-162

Bentham Science Publishers

Access to resources Recommend Favorite

Liposomes as targeted drug delivery systems in the treatment of breast cancer

By Sharma G. Anabousi S. Ehrhardt C. Ravi Kumar M. N. V.

Journal of Drug Targeting, Vol. 14, Iss. 5, 2006-06 ,pp. : 301-310

Informa Healthcare

Access to resources Recommend Favorite

Targeted Liposomal Drug Delivery in Cancer

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2981-2989

Bentham Science Publishers

Access to resources Recommend Favorite

Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer

By Laginha Kimberley Moase Elaine Yu Ning Huang Anthony Allen T. M.

Journal of Drug Targeting, Vol. 16, Iss. 7-8, 2008-08 ,pp. : 605-610

Informa Healthcare

Access to resources Recommend Favorite